Diabetes Care Devices Market By Product (Blood Glucose Monitoring Devices, Insulin Delivery Devices): Global Opportunity Analysis and Industry Forecast, 2020-2030

Diabetes Care Devices Market

A diabetes care device is used for testing blood glucose levels in a diabetic patient. In addition, these devices are used to deliver insulin to a diabetic patients. The major factors that contribute to the growth of the market include e increase in the geriatric population and a rise in sedentary lifestyles among individuals.

The major factors that contribute to the growth of the market are the rise in the prevalence of diabetes, an increase in the number of programs initiated by various health organizations related to health awareness, and favorable national health strategies. Moreover, the surge in the need for faster and safer diagnosis and treatment of diabetes and an increase in government initiatives to provide better health services are the factors that drive Diabetes Care Devices Market Growth. However, the high cost of diabetes care and adverse effects associated with some of the diabetes care devices restrain the market growth in the future..

The Diabetes Care Devices Industry is segmented on the basis of product and region. On the basis of the product, it is bifurcated into blood glucose monitoring devices and insulin delivery devices. The blood glucose monitoring devices segment is categorized into testing strips, self-monitoring blood glucose meters, lancets, and continuous glucose monitoring devices. The insulin delivery devices segment is classified into insulin syringes, insulin pens, insulin pumps, and insulin jet injectors. Region-wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, Italy, the UK, Spain, and the Rest of Europe), Asia-Pacific (China, Japan, Australia, India, South Korea, and Rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and Rest of LAMEA).

The insulin delivery devices segment dominated the market in 2020 and is expected to maintain its dominance during the forecast period, owing to the rise in prevalence of diabetes, increase in the geriatric population, the surge in demand for self-care, and technological advancements in blood glucose monitoring devices. In addition, checking blood glucose levels is the first step in the treatment of a diabetic patient. Hence, blood glucose monitoring devices are used by almost every diabetic patient. This is not the case with insulin delivery devices, as every patient diagnosed with diabetes need not take insulin injections.

There have been revolutionary advancements in the field of diabetes care devices market, including the development of continuous glucose monitoring systems, which would boost the Diabetes Care Devices Industry.

By region, Diabetes Care Devices Market Analysis is done across North America, Asia-Pacific, Europe, and LAMEA. North America accounted for more than two-fifths of Diabetes Care Devices Market Share in 2020 and is expected to remain dominant throughout the forecast period. This is attributed to an increase in the incidence of diabetes, growth in the geriatric population, and a rise in the adoption of the sedentary lifestyle of people that leads to diabetes. In addition, surge in the adoption rate of technologically advanced devices and rise in presence of highly sophisticated healthcare infrastructure are expected to present new growth opportunities to the players in this market.

KEY FINDINGS OF THE STUDY

The insulin delivery device devices segment accounted for more than half of the global market share in 2020

Blood glucose monitoring devices segment is expected to grow at a CAGR of 7.2% from 2021 to 2030

Asia-Pacific is expected to grow at the highest CAGR of 7.6%, from 2021 to 2030.

Overview

A diabetes care device is used to check the blood glucose level or the insulin level of a diabetic patient. There are mainly two types of diabetes care devices, including the blood glucose monitoring device and the insulin delivery device. Diabetes care devices include blood glucose meters, lancing devices, insulin delivery systems, and digital solutions for data management.

 

The major factor that contributes to the growth of the diabetes care devices market includes an increase in the incidence rate of diabetes, owing to urbanization and a sedentary lifestyle. Moreover, technological advancements in the field of diabetes devices, a rise in the obese population, an increase in consumption of junk food, and a surge in the need for rapid & safe diagnosis and treatment of diabetes boost the market growth. However, blood glucose monitoring devices do not measure the exact level of glucose in the blood but provide a range in which the blood glucose level of a patient lie. In addition, adverse effects associated with some of the diabetes care devices hinder the market growth. In addition, the rise in awareness about diabetes monitoring devices and untapped market opportunities in developing regions are expected to provide numerous opportunities for market growth.

 

The diabetes care devices market is segmented on the basis of product and region. Depending on the type, the market is bifurcated into blood glucose monitoring devices and insulin delivery devices. The blood glucose monitoring devices segment is categorized into testing strips, self-monitoring blood glucose meters, lancets, and continuous glucose monitoring devices. The insulin delivery devices segment is classified into insulin syringes, insulin pens, insulin pumps, and insulin jet injectors. Region-wise, it is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, Italy, the UK, Spain, and Rest of Europe), Asia-Pacific (China, Japan, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and Rest of LAMEA)

The list of key players profiled in this report includes Abbott Laboratories, ACON Laboratories, Inc., Ascension Diabetes Care Holdings AG (formerly diabetes case business of Bayer AG), Becton, Dickinson and Company, Nipro corporation., F. Hoffmann-La Roche Ltd., Johnson & Johnson, Medline Industries, Novo Nordisk A/S, and Terumo Corporation.

Key players in the value chain include Arkray, Inc., Echo Therapeutics, Inc., Glysens Incorporated, Insulet Corporation, Sanofi, and Ypsomed AG.

Key Benefits For Stakeholders

This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the diabetes care devices market analysis from 2020 to 2030 to identify the prevailing diabetes care devices market opportunities.

The market research is offered along with information related to key drivers, restraints, and opportunities.

Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.

In-depth analysis of the diabetes care devices market segmentation assists to determine the prevailing market opportunities.

Major countries in each region are mapped according to their revenue contribution to the global market.

Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.

The report includes the analysis of the regional as well as global diabetes care devices market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

TERUMO CORPORATIO

Scope of Diabetes Care Devices Market Report

1.1.Report description

1.2.Key market segments

1.3.Key benefits to the stakeholders

1.4.Research Methodology

1.4.1.Secondary research

1.4.2.Primary research

1.4.3.Analyst tools and models

2.1.Key findings of the study

2.2.CXO Perspective

3.1.Market definition and scope

3.2.Key findings

3.2.1.Top investment pockets

3.3.Porter’s five forces analysis

3.4.Top player positioning

3.5.Market dynamics

3.5.1.Drivers

3.5.2.Restraints

3.5.3.Opportunities

3.6.COVID-19 Impact Analysis on the market

4.1 Overview

4.1.1 Market size and forecast

4.2 Blood Glucose Monitoring Devices

4.2.1 Key market trends, growth factors and opportunities

4.2.2 Market size and forecast, by region

4.2.3 Market analysis by country

4.3 Insulin Delivery Devices

4.3.1 Key market trends, growth factors and opportunities

4.3.2 Market size and forecast, by region

4.3.3 Market analysis by country

5.1 Overview

5.1.1 Market size and forecast

5.2 North America

5.2.1 Key trends and opportunities

5.2.2 North America Market size and forecast, by By Product

5.2.3 North America Market size and forecast, by country

5.2.3.1 U.S.

5.2.3.1.1 Market size and forecast, by By Product

5.2.3.2 Canada

5.2.3.2.1 Market size and forecast, by By Product

5.2.3.3 Mexico

5.2.3.3.1 Market size and forecast, by By Product

5.3 Europe

5.3.1 Key trends and opportunities

5.3.2 Europe Market size and forecast, by By Product

5.3.3 Europe Market size and forecast, by country

5.3.3.1 Geramny

5.3.3.1.1 Market size and forecast, by By Product

5.3.3.2 France

5.3.3.2.1 Market size and forecast, by By Product

5.3.3.3 U.K.

5.3.3.3.1 Market size and forecast, by By Product

5.3.3.4 Italy

5.3.3.4.1 Market size and forecast, by By Product

5.3.3.5 Spain

5.3.3.5.1 Market size and forecast, by By Product

5.3.3.6 Rest of Europe

5.3.3.6.1 Market size and forecast, by By Product

5.4 Asia-Pacific

5.4.1 Key trends and opportunities

5.4.2 Asia-Pacific Market size and forecast, by By Product

5.4.3 Asia-Pacific Market size and forecast, by country

5.4.3.1 Japan

5.4.3.1.1 Market size and forecast, by By Product

5.4.3.2 China

5.4.3.2.1 Market size and forecast, by By Product

5.4.3.3 Australia

5.4.3.3.1 Market size and forecast, by By Product

5.4.3.4 India

5.4.3.4.1 Market size and forecast, by By Product

5.4.3.5 South Korea

5.4.3.5.1 Market size and forecast, by By Product

5.4.3.6 Rest of Europe

5.4.3.6.1 Market size and forecast, by By Product

5.5 LAMEA

5.5.1 Key trends and opportunities

5.5.2 LAMEA Market size and forecast, by By Product

5.5.3 LAMEA Market size and forecast, by country

5.5.3.1 Brazil

5.5.3.1.1 Market size and forecast, by By Product

5.5.3.2 Saudi Arabia

5.5.3.2.1 Market size and forecast, by By Product

5.5.3.3 South Africa

5.5.3.3.1 Market size and forecast, by By Product

5.5.3.4 Rest of LAMEA

5.5.3.4.1 Market size and forecast, by By Product

6.1. Introduction

6.2. Top winning strategies

6.3. Product Mapping of Top 10 Player

6.4. Competitive Dashboard

6.5. Competitive Heatmap

6.6. Key developments

7.1 ABBOTT LABORATORIES

7.1.1 Company overview

7.1.2 Company snapshot

7.1.3 Operating business segments

7.1.4 Product portfolio

7.1.5 Business performance

7.1.6 Key strategic moves and developments

7.2 ACON LABORATORIES, INC.

7.2.1 Company overview

7.2.2 Company snapshot

7.2.3 Operating business segments

7.2.4 Product portfolio

7.2.5 Business performance

7.2.6 Key strategic moves and developments

7.3 BECTON, DICKINSON AND COMPANY

7.3.1 Company overview

7.3.2 Company snapshot

7.3.3 Operating business segments

7.3.4 Product portfolio

7.3.5 Business performance

7.3.6 Key strategic moves and developments

7.4 JOHNSON & JOHNSON

7.4.1 Company overview

7.4.2 Company snapshot

7.4.3 Operating business segments

7.4.4 Product portfolio

7.4.5 Business performance

7.4.6 Key strategic moves and developments

7.5 MEDTRONIC PLC

7.5.1 Company overview

7.5.2 Company snapshot

7.5.3 Operating business segments

7.5.4 Product portfolio

7.5.5 Business performance

7.5.6 Key strategic moves and developments

7.6 NOVO NORDISK A/S

7.6.1 Company overview

7.6.2 Company snapshot

7.6.3 Operating business segments

7.6.4 Product portfolio

7.6.5 Business performance

7.6.6 Key strategic moves and developments

7.7 TERUMO CORPORATION

7.7.1 Company overview

7.7.2 Company snapshot

7.7.3 Operating business segments

7.7.4 Product portfolio

7.7.5 Business performance

7.7.6 Key strategic moves and development

LIST OF TABLES

TABLE 1. GLOBAL DIABETES CARE DEVICES MARKET, BY BY PRODUCT, 2020-2030,($MILLION)

TABLE 2. DIABETES CARE DEVICES MARKET REVENUE, FOR BLOOD GLUCOSE MONITORING DEVICES, BY REGION , 2020-2030,($MILLION)

TABLE 3. DIABETES CARE DEVICES MARKET BLOOD GLUCOSE MONITORING DEVICES BY COUNTRY, 2020-2030,($MILLION)

TABLE 4. DIABETES CARE DEVICES MARKET REVENUE, FOR INSULIN DELIVERY DEVICES, BY REGION , 2020-2030,($MILLION)

TABLE 5. DIABETES CARE DEVICES MARKET INSULIN DELIVERY DEVICES BY COUNTRY, 2020-2030,($MILLION)

TABLE 6. DIABETES CARE DEVICES MARKET, BY REGION, 2020-2030,($MILLION)

TABLE 7. NORTH AMERICA DIABETES CARE DEVICES MARKET, BY BY PRODUCT, 2020-2030,($MILLION)

TABLE 8. NORTH AMERICA DIABETES CARE DEVICES MARKET, BY COUNTRY, 2020-2030,($MILLION)

TABLE 9. U.S. DIABETES CARE DEVICES MARKET BY BY PRODUCT 2020-2030,($MILLION)

TABLE 10. CANADA DIABETES CARE DEVICES MARKET BY BY PRODUCT 2020-2030,($MILLION)

TABLE 11. MEXICO DIABETES CARE DEVICES MARKET BY BY PRODUCT 2020-2030,($MILLION)

TABLE 12. EUROPE DIABETES CARE DEVICES MARKET, BY BY PRODUCT, 2020-2030,($MILLION)

TABLE 13. EUROPE DIABETES CARE DEVICES MARKET, BY COUNTRY, 2020-2030,($MILLION)

TABLE 14. GERAMNY DIABETES CARE DEVICES MARKET BY BY PRODUCT 2020-2030,($MILLION)

TABLE 15. FRANCE DIABETES CARE DEVICES MARKET BY BY PRODUCT 2020-2030,($MILLION)

TABLE 16. U.K. DIABETES CARE DEVICES MARKET BY BY PRODUCT 2020-2030,($MILLION)

TABLE 17. ITALY DIABETES CARE DEVICES MARKET BY BY PRODUCT 2020-2030,($MILLION)

TABLE 18. SPAIN DIABETES CARE DEVICES MARKET BY BY PRODUCT 2020-2030,($MILLION)

TABLE 19. REST OF EUROPE DIABETES CARE DEVICES MARKET BY BY PRODUCT 2020-2030,($MILLION)

TABLE 20. ASIA-PACIFIC DIABETES CARE DEVICES MARKET, BY BY PRODUCT, 2020-2030,($MILLION)

TABLE 21. ASIA-PACIFIC DIABETES CARE DEVICES MARKET, BY COUNTRY, 2020-2030,($MILLION)

TABLE 22. JAPAN DIABETES CARE DEVICES MARKET BY BY PRODUCT 2020-2030,($MILLION)

TABLE 23. CHINA DIABETES CARE DEVICES MARKET BY BY PRODUCT 2020-2030,($MILLION)

TABLE 24. AUSTRALIA DIABETES CARE DEVICES MARKET BY BY PRODUCT 2020-2030,($MILLION)

TABLE 25. INDIA DIABETES CARE DEVICES MARKET BY BY PRODUCT 2020-2030,($MILLION)

TABLE 26. SOUTH KOREA DIABETES CARE DEVICES MARKET BY BY PRODUCT 2020-2030,($MILLION)

TABLE 27. REST OF EUROPE DIABETES CARE DEVICES MARKET BY BY PRODUCT 2020-2030,($MILLION)

TABLE 28. LAMEA DIABETES CARE DEVICES MARKET, BY BY PRODUCT, 2020-2030,($MILLION)

TABLE 29. LAMEA DIABETES CARE DEVICES MARKET, BY COUNTRY, 2020-2030,($MILLION)

TABLE 30. BRAZIL DIABETES CARE DEVICES MARKET BY BY PRODUCT 2020-2030,($MILLION)

TABLE 31. SAUDI ARABIA DIABETES CARE DEVICES MARKET BY BY PRODUCT 2020-2030,($MILLION)

TABLE 32. SOUTH AFRICA DIABETES CARE DEVICES MARKET BY BY PRODUCT 2020-2030,($MILLION)

TABLE 33. REST OF LAMEA DIABETES CARE DEVICES MARKET BY BY PRODUCT 2020-2030,($MILLION)

TABLE 34.ABBOTT LABORATORIES: COMPANY SNAPSHOT

TABLE 35.ABBOTT LABORATORIES: OPERATING SEGMENTS

TABLE 36.ABBOTT LABORATORIES: PRODUCT PORTFOLIO

TABLE 37.ABBOTT LABORATORIES: NET SALES,

TABLE 38.ABBOTT LABORATORIES: KEY STRATERGIES

TABLE 39.ACON LABORATORIES, INC.: COMPANY SNAPSHOT

TABLE 40.ACON LABORATORIES, INC.: OPERATING SEGMENTS

TABLE 41.ACON LABORATORIES, INC.: PRODUCT PORTFOLIO

TABLE 42.ACON LABORATORIES, INC.: NET SALES,

TABLE 43.ACON LABORATORIES, INC.: KEY STRATERGIES

TABLE 44.BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT

TABLE 45.BECTON, DICKINSON AND COMPANY: OPERATING SEGMENTS

TABLE 46.BECTON, DICKINSON AND COMPANY: PRODUCT PORTFOLIO

TABLE 47.BECTON, DICKINSON AND COMPANY: NET SALES,

TABLE 48.BECTON, DICKINSON AND COMPANY: KEY STRATERGIES

TABLE 49.JOHNSON & JOHNSON: COMPANY SNAPSHOT

TABLE 50.JOHNSON & JOHNSON: OPERATING SEGMENTS

TABLE 51.JOHNSON & JOHNSON: PRODUCT PORTFOLIO

TABLE 52.JOHNSON & JOHNSON: NET SALES,

TABLE 53.JOHNSON & JOHNSON: KEY STRATERGIES

TABLE 54.MEDTRONIC PLC: COMPANY SNAPSHOT

TABLE 55.MEDTRONIC PLC: OPERATING SEGMENTS

TABLE 56.MEDTRONIC PLC: PRODUCT PORTFOLIO

TABLE 57.MEDTRONIC PLC: NET SALES,

TABLE 58.MEDTRONIC PLC: KEY STRATERGIES

TABLE 59.NOVO NORDISK A/S: COMPANY SNAPSHOT

TABLE 60.NOVO NORDISK A/S: OPERATING SEGMENTS

TABLE 61.NOVO NORDISK A/S: PRODUCT PORTFOLIO

TABLE 62.NOVO NORDISK A/S: NET SALES,

TABLE 63.NOVO NORDISK A/S: KEY STRATERGIES

TABLE 64.TERUMO CORPORATION: COMPANY SNAPSHOT

TABLE 65.TERUMO CORPORATION: OPERATING SEGMENTS

TABLE 66.TERUMO CORPORATION: PRODUCT PORTFOLIO

TABLE 67.TERUMO CORPORATION: NET SALES,

TABLE 68.TERUMO CORPORATION: KEY STRATERGIES LIST OF FIGURES

FIGURE 1.DIABETES CARE DEVICES MARKET SEGMENTATION

FIGURE 2.DIABETES CARE DEVICES MARKET,2020-2030

FIGURE 3.DIABETES CARE DEVICES MARKET,2020-2030

FIGURE 4. TOP INVESTMENT POCKETS, BY REGION

FIGURE 5.PORTER FIVE-1

FIGURE 6.PORTER FIVE-2

FIGURE 7.PORTER FIVE-3

FIGURE 8.PORTER FIVE-4

FIGURE 9.PORTER FIVE-5

FIGURE 10.TOP PLAYER POSITIONING

FIGURE 11.DIABETES CARE DEVICES MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES

FIGURE 12.DIABETES CARE DEVICES MARKET,BY BY PRODUCT,2020(%)

FIGURE 13.COMPARATIVE SHARE ANALYSIS OF BLOOD GLUCOSE MONITORING DEVICES DIABETES CARE DEVICES MARKET,2020-2030(%)

FIGURE 14.COMPARATIVE SHARE ANALYSIS OF INSULIN DELIVERY DEVICES DIABETES CARE DEVICES MARKET,2020-2030(%)

FIGURE 15.DIABETES CARE DEVICES MARKET BY REGION,2020

FIGURE 16.U.S. DIABETES CARE DEVICES MARKET,2020-2030($MILLION)

FIGURE 17.CANADA DIABETES CARE DEVICES MARKET,2020-2030($MILLION)

FIGURE 18.MEXICO DIABETES CARE DEVICES MARKET,2020-2030($MILLION)

FIGURE 19.GERAMNY DIABETES CARE DEVICES MARKET,2020-2030($MILLION)

FIGURE 20.FRANCE DIABETES CARE DEVICES MARKET,2020-2030($MILLION)

FIGURE 21.U.K. DIABETES CARE DEVICES MARKET,2020-2030($MILLION)

FIGURE 22.ITALY DIABETES CARE DEVICES MARKET,2020-2030($MILLION)

FIGURE 23.SPAIN DIABETES CARE DEVICES MARKET,2020-2030($MILLION)

FIGURE 24.REST OF EUROPE DIABETES CARE DEVICES MARKET,2020-2030($MILLION)

FIGURE 25.JAPAN DIABETES CARE DEVICES MARKET,2020-2030($MILLION)

FIGURE 26.CHINA DIABETES CARE DEVICES MARKET,2020-2030($MILLION)

FIGURE 27.AUSTRALIA DIABETES CARE DEVICES MARKET,2020-2030($MILLION)

FIGURE 28.INDIA DIABETES CARE DEVICES MARKET,2020-2030($MILLION)

FIGURE 29.SOUTH KOREA DIABETES CARE DEVICES MARKET,2020-2030($MILLION)

FIGURE 30.REST OF EUROPE DIABETES CARE DEVICES MARKET,2020-2030($MILLION)

FIGURE 31.BRAZIL DIABETES CARE DEVICES MARKET,2020-2030($MILLION)

FIGURE 32.SAUDI ARABIA DIABETES CARE DEVICES MARKET,2020-2030($MILLION)

FIGURE 33.SOUTH AFRICA DIABETES CARE DEVICES MARKET,2020-2030($MILLION)

FIGURE 34.REST OF LAMEA DIABETES CARE DEVICES MARKET,2020-2030($MILLION)

FIGURE 35. TOP WINNING STRATEGIES, BY YEAR

FIGURE 36. TOP WINNING STRATEGIES, BY DEVELOPMENT

FIGURE 37. TOP WINNING STRATEGIES, BY COMPANY

FIGURE 38.PRODUCT MAPPING OF TOP 10 PLAYERS

FIGURE 39.COMPETITIVE DASHBOARD

FIGURE 40.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS

FIGURE 41.ABBOTT LABORATORIES.: NET SALES ,($MILLION)

FIGURE 42.ACON LABORATORIES, INC..: NET SALES ,($MILLION)

FIGURE 43.BECTON, DICKINSON AND COMPANY.: NET SALES ,($MILLION)

FIGURE 44.JOHNSON & JOHNSON.: NET SALES ,($MILLION)

FIGURE 45.MEDTRONIC PLC.: NET SALES ,($MILLION)

FIGURE 46.NOVO NORDISK A/S.: NET SALES ,($MILLION)

FIGURE 47.TERUMO CORPORATION.: NET SALES ,($MILLION